Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2013 | 12-2012 | |
| Sales | 18 | 0 | 0 | 2,547,300 | 2,459,700 |
| Cost of Goods | N/A | N/A | N/A | 1,067,900 | 1,023,700 |
| Gross Profit | 18 | N/A | N/A | 1,479,400 | 1,436,000 |
| Operating Expenses | 75,172 | 45,741 | 0 | 863,200 | 863,200 |
| Operating Income | -75,154 | -45,741 | N/A | 617,100 | 573,500 |
| Interest Expense | 0 | 0 | 0 | 91,600 | 109,000 |
| Other Income | -3,172 | -70,997 | 0 | -48,100 | 35,100 |
| Pre-tax Income | -78,326 | -116,738 | 0 | 477,400 | 499,600 |
| Income Tax | N/A | N/A | N/A | 111,900 | 96,200 |
| Net Income Continuous | -78,326 | -116,738 | N/A | 365,500 | 403,400 |
| Net Income Discontinuous | N/A | N/A | N/A | -3,000 | -18,200 |
| Net Income | $-78,326 | $-116,738 | $N/A | $362,500 | $385,200 |
| EPS Basic Total Ops | -14.05 | -40.54 | N/A | 2.24 | 2.43 |
| EPS Basic Continuous Ops | -12.09 | -40.34 | N/A | 2.26 | 2.55 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.12 |
| EPS Diluted Total Ops | -14.05 | -40.54 | N/A | 2.22 | 2.40 |
| EPS Diluted Continuous Ops | -12.09 | -40.34 | N/A | 2.24 | 2.51 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -14.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-72,571 | $-45,091 | $N/A | $738,100 | $684,000 |